Skip to main content

camibirstat

Generic: Camibirstat

camibirstat: 2 clinical trials tracked.

camibirstat evidence translation

What we can confirm

2 tracked trials

No verified listed developer

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about camibirstat, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence1 indications · 1 study sponsors

Related indications

Acute Myeloid Leukemia
Clinical Trials (2)

FHD-286 With Low-Dose Weekly Decitabine/Venetoclax in Patients With Acute Myeloid Leukemia

NCT07283094·Phase 1
Recruiting

Primary endpoint: Dose-limiting toxicities (DLTs)

Interventionalopen33 targetStarted 2026-02Completion 2030-021 site · United StatesMontefiore Medical Center

A Phase 1, Multicenter, Open-Label, Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of Orally Administered FHD-286, as Monotherapy or Combination Therapy, in Subjects With Advanced Hematologic Malignancies

NCT04891757·Phase 1·FHTX

Primary endpoint: Incidence of AEs, dose-limiting toxicities (DLTs), serious AEs (SAEs), AEs leading to discontinuation, and adverse events of special interest (AESIs); safety laboratory assessments

Interventionalopen144 targetStarted 2021-06Completion 2027-065 sites · United StatesFoghorn Therapeutics Inc.